Media coverage, online discussions, and high-profile public conversations around weight loss treatments have introduced GLP-1 therapy to a much wider audience than in the past
51-OR: a phase 2, randomized, double-blind, placebo-controlled, dose-finding study of BI 456906 in people with overweight/obesity
Imagine the trauma children will experience when they are told not only is their body diseased but that they need medication or surgery to fix it, reads a letter from the Collaborative of Eating Disorders Organizations, a coalition of local, national, and international groups focused on awareness of eating disorders and access to quality care
If you think you might benefit from GLP-1s, talk to your primary care doctor, Dr
Use this as your primary reference when coding any diabetes encounter
Interested in working together